Australian urologists are using Orthocell’s flagship nerve repair product Remplir in prostate cancer surgery Remplir holds promise in reducing post-surgical complications due to peripheral nerve ...

The nerve-illuminating agent rizedisben achieved sustained fluorescence during laparoscopic prostatectomy All nine patients receiving a dose of 3 mg/kg showed obturator nerve fluorescence, as well as ...

Real-world, prospective data corroborate trial results showing functional declines after prostate cancer surgery, despite progress in nerve-sparing techniques. Active surveillance best preserves ...

ALBUQUERQUE, N.M. (KRQE) – It’s a game changer in surgery. UNMH researchers are testing a new drug that makes nerves glow. Dr. Ryan Orosco at UNM Hospital helped co-author the research into the drug.

The most common surgery for prostate cancer is a radical prostatectomy. This surgery involves taking out the entire prostate gland, some lymph nodes and other nearby tissue, like the seminal vesicles ...

NEW YORK--(BUSINESS WIRE)--Illuminare Biotechnologies, a company focused on developing a nerve imaging agent to enhance surgical safety, announced first-in-human data results from a Phase 1 clinical ...